Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -176,145 | -126,710 | -94,743 | -39,506 | -132,617 |
| Depreciation Amortization | 1,392 | 963 | 539 | 227 | 564 |
| Accounts receivable | -13,651 | -4,355 | -7,487 | -3,963 | -6,951 |
| Accounts payable and accrued liabilities | -3,563 | 1,390 | -3,245 | 2,621 | 18,646 |
| Other Working Capital | -14,032 | -7,956 | -10,446 | -1,773 | 16,364 |
| Other Operating Activity | 40,281 | 21,768 | 26,703 | 4,231 | -2,817 |
| Operating Cash Flow | $-165,718 | $-114,900 | $-88,678 | $-38,163 | $-106,812 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,450 | -2,089 | -1,093 | -262 | -217 |
| Purchase Sale Intangibles | -21,442 | -1,069 | -763 | -404 | -21,105 |
| Other Investing Activity | -21,442 | -1,089 | -784 | -404 | -21,281 |
| Investing Cash Flow | $-23,892 | $-3,178 | $-1,876 | $-666 | $-21,498 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200,000 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 200,000 | 200,000 | N/A | 75,000 |
| Debt Repayment | N/A | -81,661 | -81,661 | N/A | N/A |
| Common Stock Issued | 77,140 | 109 | 100 | 100 | 91,574 |
| Other Financing Activity | -88,313 | -6,652 | -6,652 | 0 | -3,787 |
| Financing Cash Flow | $188,827 | $111,796 | $111,787 | $100 | $162,787 |
| Beginning Cash Position | 161,613 | 161,613 | 161,613 | 161,613 | 127,136 |
| End Cash Position | 160,830 | 155,330 | 182,846 | 122,884 | 161,613 |
| Net Cash Flow | $-783 | $-6,283 | $21,233 | $-38,729 | $34,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | -165,718 | -114,900 | -88,678 | -38,163 | -106,812 |
| Capital Expenditure | -2,450 | -2,089 | -1,093 | -262 | -217 |
| Free Cash Flow | -168,168 | -116,990 | -89,770 | -38,426 | -107,029 |